Study to Evaluate the Safety,Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With CF and EPI
This study has been completed.
Sponsor:
Aptalis Pharma
Information provided by:
Aptalis Pharma
ClinicalTrials.gov Identifier:
NCT00297167
First received: February 27, 2006
Last updated: August 23, 2010
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2006 |
| Primary Completion Date: | November 2006 (Final data collection date for primary outcome measure) |
No publications provided by Aptalis Pharma
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):